1832 Asset Management L.P. Oncolytics Biotech Inc Transaction History

1832 Asset Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.98 - $3.24 $9 - $16	5 New	5 $0
Q4 2020 Feb 16, 2021	SELL	$1.71 - $4.03 $719 - $1,696	-421 Reduced 98.83%	5 $0
Q1 2020 May 14, 2020	BUY	$0.98 - $4.28 $412 - $1,801	421 Added 8420.0%	426 $1,000
Q2 2018 Aug 14, 2018	BUY	$4.56 - $7.83 $22 - $39	5 New	5 $0

1.18M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $49.2M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.